Pharmaceutical Grade 1190307-88-0 Sofosbuvir Yekurapa Hepatitis C Featured Image

Pharmaceutical Giredhi 1190307-88-0 Sofosbuvir Yekurapa Hepatitis C

Tsanangudzo Pfupi:

Kuchena:≧98%, Ichena kana isina-chena crystallize poda

Quality Standard:mumba kana sezvinodiwa

Chitupa:COA, MOA, MSDS, nezvimwe

Kugona50Kg/Mwedzi

Sherufu Hupenyu:2 Makore

Application:Mushonga unoshandiswa kurapa hepatitis C

Team Advantage:Ane ruzivo rwekutengesa kunze timu ine nyanzvi yekudzidzira mufekitori

Tumira email kwatiri Dhaunirodha sePDF

Product Detail

FAQ

Product Tags

Productzita	Sofosbuvir
Mashoko anoreva zvakafanana	N-[[P(S),2'R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-L-alanine 1-methylethyl ester;PSI 7977
CAS Nha.	1190307-88-0
Chitarisiko	Muchena kana chena-chena crystallize poda
Molecular Formula	C₂₂H₂₉FN₃O₉P
Molecular Weight	529.45
Usage	Chinangwa chekutsvakurudza
Packing	Sekukumbira kwako
Storage	Chengetedza mumidziyo yakasimba, isingapindi chiedza munzvimbo inotonhorera

Sofosbuvir Cas: 1190307-88-0
Items	Standard	Results
Chitarisiko	Muchena kana chena-chena crystallize poda	Zvinoenderana
Identification	Iyo nguva yekuchengetedza yepamusoro peak yemuenzaniso mhinduro inoenderana neiyo yeyakajairwa mhinduro, sezvakawanikwa muyedzo yeAssay.	Zvinoenderana
Meltingpoint	118.0℃-128.0℃	121.9 ℃-123 ℃
Kurasikirwa pakuomeswa	NMT 0.5%	0.16%
Residual pakubatidza	NMT 0.2%	0.16%
Mvura	NMT 0.5%	0.10%
Chiral kuchena	Iyo Rp-isomer: NMT 0.2%	0.01%
Related substance	Kusachena A: NMT 0.2%Kusachena B: NMT 0.1% Kusachena C: NMT 0.1% Chero kumwe kusachena: NMT 0.2% Yese tsvina: NMT 1.0%	0.03%Haisati yaonekwa Haisati yaonekwa 0.04% 0.16%
Assay	98.0%~102.0%	98.78%
Residual Solvent	Tetrahydrofuran: NMT 720ppmDichloromethane: NMT 600ppm	0ppm0ppm
Mhedziso:zvinoenderana nezvinodiwa zvemumba.

Company Information

√ Management layer's yakazara ruzivo mufekitori uye vane hunyanzvi matekinika vateveri;
√ Hunhu ndiyo inogara ichitarisisa yedu yepamusoro, Yakasimba QC system;
√ makore gumi nerimwe ane ruzivo rwekutengesa kunze timu;
√ Yakazvimirira R&D lab;
√ Mashopu maviri akasainwa kwenguva refu eGMP;
√ Zviwanikwa zvakapfuma zvemafekitori akawanda asina basa epurojekiti yakasarudzika;
√ Yakanyanya Kubudirira inoshanda timu ine inowirirana nzira.
imgaf